Motus GI (NSDQ:MOTS) yesterday upsized a follow-on offering it prepped for late last year to $20 million. Ft. Lauderdale, Fla.-based Motus developed the Pure-Vu device, which is designed to deliver a mixture of water and air to remove debris even when patients haven’t completed their bowel prep for colonoscopies. In February 2018 the company raised […]
MOTUS GI
Zimmer Biomet taps medtech vet Upadhyay for CFO | Personnel Moves June 20 2019
Zimmer Biomet (NYSE:ZBH) said yesterday that longtime finance chief Daniel Florin is stepping down effective July 1, to be replaced as CFO by medical device veteran Suketu Upadhyay. Florin is slated to stay on in an advisory capacity “for a period following the succession,” Warsaw, Ind.-based Zimmer said. Upadhyay’s CV includes stints Bristol-Myers Squibb, Endo International, […]
Motus GI lands FDA clearance for next-gen colon prep system
Motus GI (NSDQ:MOTS) today announced it has received FDA 510(k) clearance for the second-generation of its Pure-Vu colonoscopy device. Fort Lauderdale, Fla.-based Motus designed the original Pure-Vu device to attach to standard and slim colonoscopes to deliver a mixture of water and air to remove debris when patients haven’t completed their bowel prep. Pure-Vu GEN2 […]
Motus GI preps $14m follow-on
Motus GI (NSDQ:MOTS) said yesterday that it’s preparing a follow-on offering worth nearly $14 million for its Pure-Vu colonoscopy device. Ft. Lauderdale, Fla.-based Motus said it plans to float 5 million shares at $2.70 apiece, for gross proceeds of $13.5 million. A 30-day underwriters option on a further 750,000 shares would add $2.0 million if fully […]
Positive PureVu data gives Motus GI a brief bump
Motus GI (NSDQ:MOTS) shares got quite a bump yesterday on positive data for its PureVu colonoscopy prep device, before a general market sell-off brought the stock back down to earth. Ft. Lauderdale, Fla.-based Motus GI’s PureVu device is designed to attach to standard and slim colonoscopes to deliver a mixture of water and air to remove debris […]
Motus GI taps Moran as CEO | Personnel Moves – September 25, 2018
Motus GI said today that it named Timothy Moran as its new chief executive officer, effective October 1, replacing former CEO Mark Pomeranz who will assume the role of president and COO. Moran has previously served ConvaTec‘s (LON:CTEC) Americas president and helped lead the company through its initial public offering in 2016. Prior to ConvaTec, Moran spent […]
Motus GI wins FDA nod for Pure-Vu slim colonoscopy sleeve
Motus GI said today that it won FDA 510(k) clearance for its Pure-Vu slim sleeve as part of its Pure-Vu system, intended for use during slim colonoscopies. With the clearance of the Pure-Vu slim sleeve, Motus GI said that the Pure-Vu system is now cleared for the full range of procedures in the colonoscopy market, with […]
Motus GI wins CE Mark for Pure-Vu system
Motus GI said today it won CE Mark approval in the European Union for its flagship Pure-Vu system designed to clean poorly-prepped colons during colonoscopies. Approval was supported by positive results from a 47-patient European clinical study of the Pure-Vu system in cleaning poorly prepared colons, which showed an increase in the number of adequately cleansed […]
Motus GI closes $18m IPO
Motus GI last week closed an initial public offering worth $18 million for its Pure-Vu system for intra-colonoscopy cleaning. Fort Lauderdale-based Motus said it plans to use the proceeds to commercialize Pure-Vu and for R&D, among other things. The company said it sold 3.5 million shares at $5 apiece, grossing $17.5 million, and also granted a 30-day […]
Motus GI downsizes IPO to $18m
Motus GI today priced its upcoming initial public offering, dropping the range from a midpoint of $26 million to a total of $18 million. In the offering, the Fort Lauderdale, Fla.-based company said it will offer 3.5 million shares of common stock at $5 per share, with its shares slated to begin trading on Nasdaq today […]
Motus GI sets terms for $26m IPO
Motus GI yesterday set the range for its pending initial public offering, which at the midpoint would fetch nearly $26 million. Last month the Israeli company, which makes the Pure-Vu intra-colonoscopy cleaning system, registered the IPO at roughly $28.8 million. Motus GI won FDA clearance for the device in September 2016. Yesterday Motus said it plans […]
